Cite
Kost-Alimova M, Sidhom EH, Satyam A, et al. A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury. Cell Rep Med. 2020;1(8):100137doi: 10.1016/j.xcrm.2020.100137.
Kost-Alimova, M., Sidhom, E. H., Satyam, A., Chamberlain, B. T., Dvela-Levitt, M., Melanson, M., Alper, S. L., Santos, J., Gutierrez, J., Subramanian, A., Byrne, P. J., Grinkevich, E., Reyes-Bricio, E., Kim, C., Clark, A. R., Watts, A. J. B., Thompson, R., Marshall, J., Pablo, J. L., Coraor, J., Roignot, J., Vernon, K. A., Keller, K., Campbell, A., Emani, M., Racette, M., Bazua-Valenti, S., Padovano, V., Weins, A., McAdoo, S. P., Tam, F. W. K., Ronco, L., Wagner, F., Tsokos, G. C., Shaw, J. L., & Greka, A. (2020). A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury. Cell reports. Medicine, 1(8), 100137. https://doi.org/10.1016/j.xcrm.2020.100137
Kost-Alimova, Maria, et al. "A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury." Cell reports. Medicine vol. 1,8 (2020): 100137. doi: https://doi.org/10.1016/j.xcrm.2020.100137
Kost-Alimova M, Sidhom EH, Satyam A, Chamberlain BT, Dvela-Levitt M, Melanson M, Alper SL, Santos J, Gutierrez J, Subramanian A, Byrne PJ, Grinkevich E, Reyes-Bricio E, Kim C, Clark AR, Watts AJB, Thompson R, Marshall J, Pablo JL, Coraor J, Roignot J, Vernon KA, Keller K, Campbell A, Emani M, Racette M, Bazua-Valenti S, Padovano V, Weins A, McAdoo SP, Tam FWK, Ronco L, Wagner F, Tsokos GC, Shaw JL, Greka A. A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury. Cell Rep Med. 2020 Oct 29;1(8):100137. doi: 10.1016/j.xcrm.2020.100137. eCollection 2020 Nov 17. PMID: 33294858; PMCID: PMC7691435.
Copy
Download .nbib